Use of Care Pathway to Improve Airway Clearance Therapy in Adults with Cystic Fibrosis
Thursday, March 11, 2021 at 12:10 PM–12:40 PM EST add to calendar
Posters
Topic of Interest
CNS Improving Outcomes
Abstract
Cystic Fibrosis is a life-limiting disorder that affects many organ systems, but primarily the lungs. In Cystic Fibrosis, the loss of chloride transport causes airway mucus obstruction, leading to chronic airway infection and inflammation. Airway Clearance Therapy is essential to the care and treatment of patients with Cystic Fibrosis. The aim of this presentation is to demonstrate how the use of a Multidisciplinary Care Pathway can improve care delivery and Airway Clearance Therapy. At a large academic medical center, Airway Clearance Therapy increased by 50% over a three quarter period following the implementation of a care pathway.
Primary Presenters
Nakita Johns, The Ohio State University Wexner Medical Center
Co-Authors
—